Figure 4.
PFS in patients who had 1 or more prior BCMA-targeted therapy vs BCMA therapy–naïve patients.

PFS in patients who had 1 or more prior BCMA-targeted therapy vs BCMA therapy–naïve patients.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal